» Articles » PMID: 16299259

Stem Cell Mobilization by Hyperbaric Oxygen

Overview
Date 2005 Nov 22
PMID 16299259
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

We hypothesized that exposure to hyperbaric oxygen (HBO(2)) would mobilize stem/progenitor cells from the bone marrow by a nitric oxide (*NO) -dependent mechanism. The population of CD34(+) cells in the peripheral circulation of humans doubled in response to a single exposure to 2.0 atmospheres absolute (ATA) O(2) for 2 h. Over a course of 20 treatments, circulating CD34(+) cells increased eightfold, although the overall circulating white cell count was not significantly increased. The number of colony-forming cells (CFCs) increased from 16 +/- 2 to 26 +/- 3 CFCs/100,000 monocytes plated. Elevations in CFCs were entirely due to the CD34(+) subpopulation, but increased cell growth only occurred in samples obtained immediately posttreatment. A high proportion of progeny cells express receptors for vascular endothelial growth factor-2 and for stromal-derived growth factor. In mice, HBO(2) increased circulating stem cell factor by 50%, increased the number of circulating cells expressing stem cell antigen-1 and CD34 by 3.4-fold, and doubled the number of CFCs. Bone marrow *NO concentration increased by 1,008 +/- 255 nM in association with HBO(2). Stem cell mobilization did not occur in knockout mice lacking genes for endothelial *NO synthase. Moreover, pretreatment of wild-type mice with a *NO synthase inhibitor prevented the HBO(2)-induced elevation in stem cell factor and circulating stem cells. We conclude that HBO(2) mobilizes stem/progenitor cells by stimulating *NO synthesis.

Citing Articles

100% oxygen mobilizes stem cells and up-regulates MIF and APRIL in humans: a new point on the hormetic dose curve.

MacLaughlin K, Barton G, MacLaughlin J, Lamers J, Marcou M, OBrien M Front Cell Dev Biol. 2025; 12:1377203.

PMID: 39974348 PMC: 11836035. DOI: 10.3389/fcell.2024.1377203.


Case report: Successful treatment of hyperbaric oxygen for radiation-induced hemorrhagic cystitis in a 95-year-old patient with bladder cancer.

Lin L, He M, Zeng Y, Ni X, Guo Y, Xie X Front Oncol. 2025; 15:1410148.

PMID: 39963111 PMC: 11830598. DOI: 10.3389/fonc.2025.1410148.


Emerging Indications for Hyperbaric Oxygen Treatment: Registry Cohort Study.

Tanaka H, Rees J, Zhang Z, Ptak J, Hannigan P, Silverman E Interact J Med Res. 2024; 13:e53821.

PMID: 39078624 PMC: 11372337. DOI: 10.2196/53821.


An expert consensus on prevention, diagnosis, and management of hemorrhagic cystitis in pediatric hematopoietic cell transplantation, on behalf of the Infectious Disease and Hematopoietic Cell Transplant Working groups of Italian Pediatric....

DellOrso G, Carlucci M, Cesaro S, Olcese E, Balduzzi A, Vendemini F Bone Marrow Transplant. 2024; 59(9):1302-1308.

PMID: 38909124 DOI: 10.1038/s41409-024-02320-4.


Hyperoxia: Effective Mechanism of Hyperbaric Treatment at Mild-Pressure.

Cannellotto M, Yasells Garcia A, Landa M Int J Mol Sci. 2024; 25(2).

PMID: 38255851 PMC: 10815786. DOI: 10.3390/ijms25020777.